Shingles Vaccine Market Segmentation
Shingles Vaccine Product Outlook (USD Billion, 2019-2032)
Shingles Vaccine Vaccine Type Outlook (USD Billion, 2019-2032)
Shingles Vaccine Regional Outlook (USD Billion, 2019-2032)
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL SHINGLES VACCINE MARKET, BY PRODUCT
6.1. Overview
6.2. Shingrix
6.3. Zostavax
6.4. SKYZoster
7. GLOBAL SHINGLES VACCINE MARKET, BY VACCINE TYPE
7.1. Overview
7.2. Recombinant Vaccine
7.3. Live Attenuated Vaccine
8. GLOBAL SHINGLES VACCINE MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Shingles Vaccine Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Shingles Vaccine Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure, 2023
10. COMPANY PROFILES
10.1. GlaxoSmithKline plc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Merck & Co., Inc.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. SK chemicals
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Green Cross Corp
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Geneone Life Science
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Vaccitech
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. CanSinoBIO
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Pfizer Inc
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Jiangsu Recbio Technology Co., Ltd
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL SHINGLES VACCINE MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL SHINGLES VACCINE MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 7 US: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 US: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 9 CANADA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 CANADA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 7 ITALY: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 ITALY: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 11 UK: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 12 UK: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 19 CHINA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 CHINA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 21 INDIA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 22 INDIA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: SHINGLES VACCINE MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: SHINGLES VACCINE MARKET, BY VACCINE TYPE, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SHINGLES VACCINE MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SHINGLES VACCINE MARKET
FIGURE 4 GLOBAL SHINGLES VACCINE MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL SHINGLES VACCINE MARKET, SHARE (%), BY VACCINE TYPE, 2023
FIGURE 6 GLOBAL SHINGLES VACCINE MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: SHINGLES VACCINE MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: SHINGLES VACCINE MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: SHINGLES VACCINE MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: SHINGLES VACCINE MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL SHINGLES VACCINE MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 GLAXOSMITHKLINE PLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 GLAXOSMITHKLINE PLC.: SWOT ANALYSIS
FIGURE 14 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 MERCK & CO., INC.: SWOT ANALYSIS
FIGURE 16 SK CHEMICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 SK CHEMICALS: SWOT ANALYSIS
FIGURE 18 GREEN CROSS CORP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 GREEN CROSS CORP: SWOT ANALYSIS
FIGURE 20 GENEONE LIFE SCIENCE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 GENEONE LIFE SCIENCE: SWOT ANALYSIS
FIGURE 22 VACCITECH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 VACCITECH: SWOT ANALYSIS
FIGURE 24 CANSINOBIO: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 CANSINOBIO: SWOT ANALYSIS
FIGURE 26 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PFIZER INC: SWOT ANALYSIS
FIGURE 28 JIANGSU RECBIO TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 JIANGSU RECBIO TECHNOLOGY CO., LTD: SWOT ANALYSIS
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
